Zymeworks Inc (NAS:ZYME)
$ 8.98 -0.14 (-1.54%) Market Cap: 634.93 Mil Enterprise Value: 325.00 Mil PE Ratio: 0 PB Ratio: 1.45 GF Score: 78/100

Zymeworks Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 11:30AM GMT
Release Date Price: $6.87 (-1.86%)
Frank Tang

Hello, everyone. I'm Frank Tang with the investment banking team at Morgan Stanley. I'm very pleased here to have Zymeworks with us today. Just quickly before we get started, I need to read a disclosure statement. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

So we're excited to be on stage today with Chairman and CEO, Kenneth Galbraith; as well as CFO, Chris Astle. Maybe I'll just turn it over quickly for you guys to introduce yourself before we jump into some Q&A.

Kenneth H. Galbraith
Zymeworks Inc. - CEO & Chairman of the Board

That's great. No, thanks, Frank. I really appreciate being back here again at Morgan Stanley to update you on our progress. Although it's really early in the morning, but I appreciate all those who are in attendance today. I'm Ken Galbraith, I'm the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot